ACXPVSBTAI• 3 Months (Normalized)
ACXP vs BTAI (Acurx Pharmaceuticals Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Jun, 13 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACXP Performance $1.4
-10.83%
Acurx Pharmaceuticals Inc.
Normalized Baseline0.00%
BTAI Performance $0.05
-95.6%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ACXP LEADS
+84.77%
ACXP outperforming by 84.77%
ACXPBTAI
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACXP BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ACXP Price | ACXP Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.40 | -10.83% | $0.05 | -95.60% | +84.77% |
| Sep 10, 2026 | $1.40 | -10.83% | $0.05 | -95.69% | +84.86% |
| Sep 09, 2026 | $1.41 | -10.19% | $0.05 | -95.95% | +85.76% |
| Sep 08, 2026 | $1.43 | -8.92% | $0.04 | -96.29% | +87.37% |
| Sep 04, 2026 | $1.42 | -9.55% | $0.07 | -93.63% | +84.08% |
| Sep 03, 2026 | $1.40 | -10.83% | $0.12 | -89.83% | +79.00% |
| Sep 02, 2026 | $1.43 | -8.92% | $0.11 | -90.78% | +81.86% |
| Sep 01, 2026 | $1.40 | -10.83% | $0.14 | -88.19% | +77.36% |
| Aug 31, 2026 | $1.45 | -7.64% | $0.16 | -85.95% | +78.31% |
| Aug 28, 2026 | $1.44 | -8.28% | $0.18 | -84.40% | +76.12% |
| Aug 27, 2026 | $1.46 | -7.01% | $0.72 | -38.02% | +31.01% |
| Aug 26, 2026 | $1.43 | -8.92% | $0.78 | -32.76% | +23.84% |
| Aug 25, 2026 | $1.41 | -10.19% | $0.74 | -36.03% | +25.84% |
| Aug 24, 2026 | $1.40 | -10.83% | $0.76 | -34.40% | +23.57% |
| Aug 21, 2026 | $1.47 | -6.37% | $0.80 | -30.69% | +24.32% |
Page 1 of 5